These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7816963)

  • 41. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions.
    Leeflang MM; Moons KG; Reitsma JB; Zwinderman AH
    Clin Chem; 2008 Apr; 54(4):729-37. PubMed ID: 18258670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.
    Pepe MS; Feng Z; Longton G; Koopmeiners J
    Stat Med; 2009 Feb; 28(5):762-79. PubMed ID: 19097251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A general approach to sample size determination for prevalence surveys that use dual test protocols.
    Cheng D; Stamey JD; Branscum AJ
    Biom J; 2007 Aug; 49(5):694-706. PubMed ID: 17722203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjusting for differential-verification bias in diagnostic-accuracy studies: a Bayesian approach.
    de Groot JA; Dendukuri N; Janssen KJ; Reitsma JB; Bossuyt PM; Moons KG
    Epidemiology; 2011 Mar; 22(2):234-41. PubMed ID: 21228702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of violating local independence on IRT parameter estimation for the Binomial Trials Model.
    Looney MA; Spray JA
    Res Q Exerc Sport; 1992 Dec; 63(4):356-9. PubMed ID: 1439159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bias correction of two-state latent Markov process parameter estimates under misclassification.
    Rosychuk RJ; Thompson ME
    Stat Med; 2003 Jun; 22(12):2035-55. PubMed ID: 12802821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Applications of multiple imputation to the analysis of censored regression data.
    Wei GC; Tanner MA
    Biometrics; 1991 Dec; 47(4):1297-309. PubMed ID: 1786320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the power of the test for cluster bias.
    Jak S; Oort FJ
    Br J Math Stat Psychol; 2015 Nov; 68(3):434-55. PubMed ID: 25776804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A bias correction for covariance estimators to improve inference with generalized estimating equations that use an unstructured correlation matrix.
    Westgate PM
    Stat Med; 2013 Jul; 32(16):2850-8. PubMed ID: 23255154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bias properties of Bayesian statistics in finite mixture of negative binomial regression models in crash data analysis.
    Park BJ; Lord D; Hart JD
    Accid Anal Prev; 2010 Mar; 42(2):741-9. PubMed ID: 20159102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
    Wruck LM; Yiannoutsos CT; Hughes MD
    Stat Med; 2006 Oct; 25(20):3458-73. PubMed ID: 16374904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sample size calculation should be performed for design accuracy in diagnostic test studies.
    Flahault A; Cadilhac M; Thomas G
    J Clin Epidemiol; 2005 Aug; 58(8):859-62. PubMed ID: 16018921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening without a "gold standard": the Hui-Walter paradigm revisited.
    Johnson WO; Gastwirth JL; Pearson LM
    Am J Epidemiol; 2001 May; 153(9):921-4. PubMed ID: 11323324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
    Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
    Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating incidence rates with misclassified disease status: a likelihood-based approach, with application to hepatitis C virus.
    Shebl FM; El-Kamary SS; Shardell M; Langenberg P; Dorgham LS; Maguire JH; Magder LS
    Int J Infect Dis; 2012 Jul; 16(7):e527-31. PubMed ID: 22543295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of conditional dependence on the evaluation of diagnostic tests.
    Vacek PM
    Biometrics; 1985 Dec; 41(4):959-68. PubMed ID: 3830260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of two data sources to estimate odds ratios in case-control studies.
    Drews CD; Flanders WD; Kosinski AS
    Epidemiology; 1993 Jul; 4(4):327-35. PubMed ID: 8347743
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.